home / stock / ipcif / ipcif quote
Last: | $0.06 |
---|---|
Change Percent: | -14.29% |
Open: | $0.09 |
Close: | $0.07 |
High: | $0.09 |
Low: | $0.06 |
Volume: | 10,050 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.06 | $0.09 | $0.07 | $0.09 | $0.06 | 10,050 | 04-19-2024 |
$0.07 | $0.1075 | $0.07 | $0.1075 | $0.07 | 4,177 | 04-18-2024 |
$0.135 | $0 | $0.135 | $0 | $0 | 3 | 04-17-2024 |
$0.135 | $0.06 | $0.135 | $0.135 | $0.06 | 16,300 | 04-16-2024 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 10,000 | 04-12-2024 |
$0.0705 | $0 | $0.0705 | $0 | $0 | 4 | 04-11-2024 |
$0.0705 | $0 | $0.0705 | $0 | $0 | 34 | 04-10-2024 |
$0.0705 | $0.06 | $0.0705 | $0.0705 | $0.06 | 2,921 | 04-09-2024 |
$0.0724 | $0.0724 | $0.0724 | $0.0724 | $0.0724 | 2,085 | 04-08-2024 |
$0.0707 | $0.0811 | $0.0707 | $0.0811 | $0.0707 | 20,200 | 04-03-2024 |
$0.07612 | $0.0844 | $0.07612 | $0.0844 | $0.07612 | 10,000 | 04-02-2024 |
$0.0848 | $0.0786 | $0.0848 | $0.0848 | $0.0786 | 5,131 | 04-01-2024 |
$0.0712 | $0.07116 | $0.07116 | $0.0712 | $0.0712 | 103 | 03-29-2024 |
$0.07116 | $0.07116 | $0.07116 | $0.07116 | $0.07116 | 103 | 03-28-2024 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 1,660 | 03-27-2024 |
$0.08 | $0.07 | $0.08 | $0.08 | $0.055 | 78,050 | 03-26-2024 |
$0.05 | $0.0312 | $0.05 | $0.05 | $0.0312 | 2,476 | 03-25-2024 |
$0.0814 | $0 | $0.0814 | $0 | $0 | 38 | 03-22-2024 |
$0.0814 | $0.07 | $0.0814 | $0.0814 | $0.07 | 10,000 | 03-21-2024 |
$0.0406 | $0.07 | $0.0406 | $0.07 | $0.0405 | 13,494 | 03-20-2024 |
News, Short Squeeze, Breakout and More Instantly...
Intellipharmaceutics International Inc Company Name:
IPCIF Stock Symbol:
OTCMKTS Market:
TORONTO, ON / ACCESSWIRE / March 13, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - (" Intellipharmaceutics " or the " Company "), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-rel...
TORONTO, ON / ACCESSWIRE / February 26, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) (" Intellipharmaceutics " or the " Company "), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-re...
TORONTO, ON / ACCESSWIRE / February 8, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release...